Sun Pharma Advanced Research Company Limited (NSE:SPARC)
124.94
-4.61 (-3.56%)
At close: Jan 23, 2026
NSE:SPARC Market Cap
NSE:SPARC has a market cap or net worth of 40.55 billion as of January 23, 2026. Its market cap has decreased by -35.16% in one year.
Market Cap
40.55B
Enterprise Value
44.70B
Revenue
595.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
124.94
Market Cap Chart
Since July 18, 2007, NSE:SPARC's market cap has increased from 17.19B to 40.55B, an increase of 135.91%. That is a compound annual growth rate of 4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 40.55B | -7.07% |
| Dec 31, 2025 | 43.63B | -32.96% |
| Dec 31, 2024 | 65.08B | -30.07% |
| Dec 29, 2023 | 93.07B | 62.05% |
| Dec 30, 2022 | 57.43B | -24.01% |
| Dec 31, 2021 | 75.58B | 48.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 105.74B |
| Strides Pharma Science | 79.69B |
| Aarti Pharmalabs | 68.91B |
| Akums Drugs and Pharmaceuticals | 64.38B |
| Innova Captab | 37.44B |
| RPG Life Sciences | 36.65B |
| Orchid Pharma | 35.76B |
| Solara Active Pharma Sciences | 25.74B |